Eam Global Investors LLC Collegium Pharmaceutical, Inc Transaction History

Eam Global Investors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $2.01 Million - $3.06 Million	-130,030 Closed	0 $0
Q1 2020 May 13, 2020	BUY	$13.89 - $25.45 $227,670 - $417,150	16,391 Added 14.42%	130,030 $2.12 Million
Q4 2019 Feb 10, 2020	BUY	$10.7 - $22.24 $1.22 Million - $2.53 Million	113,639 New	113,639 $2.34 Million
Q2 2018 Aug 03, 2018	SELL	$21.79 - $28.29 $919,385 - $1.19 Million	-42,193 Closed	0 $0
Q1 2018 Jun 04, 2018	BUY	$18.15 - $29.21 $765,802 - $1.23 Million	42,193 New	42,193 $1.08 Million

255

36.9M

100K

21.1K

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $992M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Global Investors LLC with notifications on news.